To include your compound in the COVID-19 Resource Center, submit it here.
PixarBio proposed to acquire InVivo for $100 million in stock. The combined company would be renamed Reynolds Therapeutics Corp. and focus on pain,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury